Biotechnology and Medical Research (TRBC)

U.S. stock fund flows decline week after one of biggest inflows of 2017

U.S. stock fund flows decline week after one of biggest inflows of 2017

Published 22/06/2017

A U.S. five dollar note is seen in this illustration photo June 1, 2017. REUTERS/Thomas White/Illustration

Investors pulled back from U.S.-based stock funds after pouring the most cash into those investments since February the previous week, Lipper data showed on Thursday.

[more…]

Relatives of people with fatty liver cirrhosis also at risk

Relatives of people with fatty liver cirrhosis also at risk

Published 22/06/2017

By Shereen Lehman(Reuters Health) - If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person's odds of having liver sc

[more…]

U.S.-based taxable bond funds attract $3 billion in week: Lipper

U.S.-based taxable bond funds attract $3 billion in week: Lipper

Published 22/06/2017

A U.S. five dollar note is seen in this illustration photo June 1, 2017. REUTERS/Thomas White/Illustration

Investors poured $3 billion into U.S.-based taxable bond funds during the latest week despite incurring some losses, Lipper data showed on Thursday.

[more…]

Israel`s Gamida Cell raises $40 million for bone marrow trial

Israel`s Gamida Cell raises $40 million for bone marrow trial

Published 19/06/2017

Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

[more…]

New test may turn AZ`s Lynparza into precision drug for prostate cancer

New test may turn AZ`s Lynparza into precision drug for prostate cancer

Published 18/06/2017

FILE PHOTO: The logo of AstraZeneca is seen on a medication package in a pharmacy in London, Britain, April 28, 2014. REUTERS/Stefan Wermuth/File Photo

Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine for prostate cancer.

[more…]

Sanofi chief says U.S. Supreme Court ruling on biologics has “immediate impact”

Sanofi chief says U.S. Supreme Court ruling on biologics has “immediate impact”

Published 16/06/2017

FILE PHOTO - French multinational pharmaceutical company SANOFI logo seen at their headquaters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

The U.S Supreme Court decision to speed access to copycat biologics drugs on Monday was expected but has an "immediate impact", Sanofi Chief Executive told Reuters.

[more…]

Centrexion`s chili-based painkiller offers relief for 6 months – study

Centrexion`s chili-based painkiller offers relief for 6 months – study

Published 13/06/2017

A synthetic version of a medicine traditionally extracted from chili plant relieved knee pain among osteoarthritis patients for up to six months, data showed, bringing Centrexion Therapeutics a step closer to developing a safe and effective analgesic.

[more…]

Are drones a fast way to deliver emergency defibrillators?

Are drones a fast way to deliver emergency defibrillators?

Published 13/06/2017

A drone hovers at a viewpoint overlooking the Space Needle and skyline of tech hub Seattle, Washington, U.S. February 11, 2017. REUTERS/Chris Helgren

By Lisa Rapaport(Reuters Health) - Drones may be able to rush emergency defibrillators to patients in cardiac arrest faster than traditional emergenc

[more…]

Sanofi-Regeneron`s Praluent cuts cholesterol in Odyssey trials

Sanofi-Regeneron`s Praluent cuts cholesterol in Odyssey trials

Published 11/06/2017

France's Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol.

[more…]

In major breakthrough, tiny Utah firm regenerates skin, hair in pigs

In major breakthrough, tiny Utah firm regenerates skin, hair in pigs

Published 08/06/2017

A small U.S. biotech has successfully regenerated skin and stimulated hair growth in pigs with burns and abrasions, paving the way for a scientific breakthrough that could lead to the regeneration of fully functional human skin.

[more…]